Skip to main content
IQV
NYSE Industrial Applications And Services

IQVIA CEO Ari Bousbib Exercises $12.2M in Options, Then Sells $26.1M on the Open Market

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$235.02
Mkt Cap
$38.684B
52W Low
$154.5
52W High
$251.36
52W Position info
52% above low
Off High info
6.5% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

IQV sits 52% above its 52-week low of $154.5.

Summary

IQVIA CEO Ari Bousbib exercised $12.2M in expiring stock appreciation rights and sold $26.1M worth of shares on the open market, reducing his direct stake by about 11%.


Key Events · Ownership and Investor Activity · IQV

  • CEO Sells $26.1M in Open Market

    Ari Bousbib sold 106,279 shares at prices ranging from $244.78 to $247.10, generating $26.1 million in proceeds.

  • Exercised $12.2M in Expiring Options

    Exercised 156,206 stock appreciation rights at $78.21, acquiring shares worth $12.2 million. The options were set to expire February 2, 2027.

  • Net Reduction in CEO Stake

    Post-transaction, Bousbib's direct holdings fell from 992,147 to 835,941 shares, an 11% decrease, though he retains 543,302 shares indirectly via a trust.

  • Transaction Follows Strong Q2 Results

    The sale occurred two days after IQVIA reported Q2 revenue of $4.37 billion and adjusted EPS of $3.15, both above the high end of guidance.


Analysis · IQV · Industrial Applications And Services

Chairman and CEO Ari Bousbib exercised 156,206 stock appreciation rights at $78.21, acquiring shares worth $12.2 million, and immediately sold 106,279 of those shares on the open market for $26.1 million at prices between $244.78 and $247.10. To cover the exercise cost and taxes, an additional 49,927 shares were surrendered to the company at $244.60–$247.00. The net effect is a $26.1 million cash-out by the CEO, reducing his direct holdings by roughly 11% (from 992,147 to 835,941 shares). While option exercises are routine, the scale of the open-market sale — representing 0.162% of IQVIA's $38.7 billion market cap — is notable, especially coming just days after strong Q2 results that beat guidance. The transaction does not necessarily signal a negative outlook, as the exercised options were expiring in February 2027 and the sale may reflect personal financial planning, but it is a material insider liquidity event that investors should note.

At the time of this filing, IQV was trading at $235.02 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $38.7B. The 52-week trading range was $154.50 to $251.36. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IQV - Latest Insights

IQV
Jul 28, 2026, 4:38 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $242.94
Real-time Price: $235.02 info
Change: -$7.92 (-3%) info
Market Cap: $38.684B info
IQV
Jul 28, 2026, 7:03 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $234.00
Real-time Price: $235.02 info
Change: +$1.02 (+0.44%) info
Market Cap: $38.684B info
IQV
Jul 28, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $234.00
Real-time Price: $235.02 info
Change: +$1.02 (+0.44%) info
Market Cap: $38.684B info
IQV
Jun 11, 2026, 4:46 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $181.06
Real-time Price: $235.02 info
Change: +$53.96 (+30%) info
Market Cap: $38.684B info
IQV
Jun 04, 2026, 5:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $186.88
Real-time Price: $235.02 info
Change: +$48.14 (+26%) info
Market Cap: $38.684B info